Madrigal Pharmaceuticals ...

NASDAQ: MDGL · Real-Time Price · USD
369.75
-1.62 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
357.00
-3.45%
After-hours: Aug 15, 2025, 05:47 PM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-465.89M -373.63M -295.35M -241.85M
Depreciation & Amortization
696K 527K 467K 405K
Stock-Based Compensation
79.88M 49.73M 31.63M 26.87M
Other Working Capital
-13K -7.49M 35.15M 10.29M
Other Non-Cash Items
2.09M 2.41M 797K 7.32M
Deferred Income Tax
n/a n/a n/a -7.32M
Change in Working Capital
-72.34M -3.28M 37.6M 30.65M
Operating Cash Flow
-455.57M -324.23M -224.86M -183.92M
Capital Expenditures
-1.46M -1.48M -217K -209K
Cash Acquisitions
n/a n/a -3K 787K
Purchase of Investments
-1.13B -834.44M -143.48M -394.12M
Sales Maturities Of Investments
839.19M 333.4M 350.38M 389.27M
Other Investing Acitivies
19.09M n/a 3K -787K
Investing Cash Flow
-274.39M -502.52M 206.69M -5.05M
Debt Repayment
n/a 65M 50M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
337.57M 269.93M 8.07M 1.03M
Financial Cash Flow
735.06M 595.12M 313.45M 171.24M
Net Cash Flow
5.1M -231.63M 295.28M -17.73M
Free Cash Flow
-457.03M -325.71M -225.07M -184.13M